TY - JOUR AU - Aquino, C. C. AU - Lang, A. E. PY - 2014 DA - 2014// TI - Tardive dyskinesia syndromes: current concepts JO - Parkinsonism Relat Disord VL - 20 UR - https://doi.org/10.1016/S1353-8020(13)70028-2 DO - 10.1016/S1353-8020(13)70028-2 ID - Aquino2014 ER - TY - JOUR AU - Lerner, P. P. AU - Miodownik, C. AU - Lerner, V. PY - 2015 DA - 2015// TI - Tardive dyskinesia (syndrome): current concept and modern approaches to its management JO - Psychiatry Clin Neurosci VL - 69 UR - https://doi.org/10.1111/pcn.12270 DO - 10.1111/pcn.12270 ID - Lerner2015 ER - TY - JOUR AU - Jain, R. a. k. e. s. h. AU - Correll, C. h. r. i. s. t. o. p. h. U. PY - 2018 DA - 2018// TI - Tardive Dyskinesia: Recognition, Patient Assessment, and Differential Diagnosis JO - The Journal of Clinical Psychiatry VL - 79 UR - https://doi.org/10.4088/JCP.nu17034ah1c DO - 10.4088/JCP.nu17034ah1c ID - Jain2018 ER - TY - JOUR AU - Stegmayer, K. AU - Walther, S. AU - Harten, P. PY - 2018 DA - 2018// TI - Tardive dyskinesia associated with atypical antipsychotics: prevalence, mechanisms and management strategies JO - CNS Drugs VL - 32 UR - https://doi.org/10.1007/s40263-018-0494-8 DO - 10.1007/s40263-018-0494-8 ID - Stegmayer2018 ER - TY - JOUR AU - Tarsy, D. AU - Baldessarini, R. J. PY - 1984 DA - 1984// TI - Tardive dyskinesia JO - Annu Rev Med VL - 35 UR - https://doi.org/10.1146/annurev.me.35.020184.003133. DO - 10.1146/annurev.me.35.020184.003133. ID - Tarsy1984 ER - TY - JOUR AU - Cornett, E. M. AU - Novitch, M. AU - Kaye, A. D. AU - Kata, V. AU - Kaye, A. M. PY - 2017 DA - 2017// TI - Medication-induced tardive dyskinesia: a review and update JO - Ochsner J VL - 17 ID - Cornett2017 ER - TY - JOUR AU - Rana, A. Q. AU - Chaudry, Z. M. AU - Blanchet, P. J. PY - 2013 DA - 2013// TI - New and emerging treatments for symptomatic tardive dyskinesia JO - Drug Des Devel Ther VL - 7 UR - https://doi.org/10.2147/DDDT.S32328 DO - 10.2147/DDDT.S32328 ID - Rana2013 ER - TY - JOUR AU - Savitt, D. AU - Jankovic, J. PY - 2018 DA - 2018// TI - Tardive syndromes JO - J Neurol Sci VL - 389 UR - https://doi.org/10.1016/j.jns.2018.02.005 DO - 10.1016/j.jns.2018.02.005 ID - Savitt2018 ER - TY - STD TI - Waln O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov (N Y). 2013;3. https://doi.org/10.7916/D88P5Z71. ID - ref9 ER - TY - JOUR AU - Mathews, M. AU - Gratz, S. AU - Adetunji, B. AU - George, V. AU - Mathews, M. AU - Basil, B. PY - 2005 DA - 2005// TI - Antipsychotic-induced movement disorders: evaluation and treatment JO - Psychiatry (Edgmont) VL - 2 ID - Mathews2005 ER - TY - JOUR AU - Solmi, M. AU - Pigato, G. AU - Kane, J. M. AU - Correll, C. U. PY - 2018 DA - 2018// TI - Clinical risk factors for the development of tardive dyskinesia JO - J Neurol Sci VL - 389 UR - https://doi.org/10.1016/j.jns.2018.02.012 DO - 10.1016/j.jns.2018.02.012 ID - Solmi2018 ER - TY - JOUR AU - Chouinard, G. AU - Annable, L. AU - Ross-Chouinard, A. AU - Mercier, P. PY - 1988 DA - 1988// TI - A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases JO - J Clin Psychopharmacol VL - 8 ID - Chouinard1988 ER - TY - JOUR AU - Morgenstern, H. AU - Glazer, W. M. PY - 1993 DA - 1993// TI - Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications: results of the Yale tardive dyskinesia study JO - Arch Gen Psychiatry VL - 50 UR - https://doi.org/10.1001/archpsyc.1993.01820210057007 DO - 10.1001/archpsyc.1993.01820210057007 ID - Morgenstern1993 ER - TY - JOUR AU - Tenback, D. E. AU - Harten, P. N. AU - Slooff, C. J. AU - Os, J. PY - 2006 DA - 2006// TI - Evidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) study JO - Am J Psychiatry VL - 163 UR - https://doi.org/10.1176/ajp.2006.163.8.1438 DO - 10.1176/ajp.2006.163.8.1438 ID - Tenback2006 ER - TY - JOUR AU - Tenback, D. E. AU - Harten, P. N. AU - Os, J. PY - 2009 DA - 2009// TI - Non-therapeutic risk factors for onset of tardive dyskinesia in schizophrenia: a meta-analysis JO - Mov Disord VL - 24 UR - https://doi.org/10.1002/mds.22707 DO - 10.1002/mds.22707 ID - Tenback2009 ER - TY - JOUR AU - Tarsy, D. AU - Baldessarini, R. J. PY - 2006 DA - 2006// TI - Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? JO - Mov Disord VL - 21 UR - https://doi.org/10.1002/mds.20823 DO - 10.1002/mds.20823 ID - Tarsy2006 ER - TY - JOUR AU - Correll, C. U. AU - Schenk, E. M. PY - 2008 DA - 2008// TI - Tardive dyskinesia and new antipsychotics JO - Curr Opin Psychiatry VL - 21 UR - https://doi.org/10.1097/YCO.0b013e3282f53132 DO - 10.1097/YCO.0b013e3282f53132 ID - Correll2008 ER - TY - JOUR AU - Caroff, S. N. AU - Hurford, I. AU - Lybrand, J. AU - Campbell, E. C. PY - 2011 DA - 2011// TI - Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial JO - Neurol Clin VL - 29 UR - https://doi.org/10.1016/j.ncl.2010.10.002 DO - 10.1016/j.ncl.2010.10.002 ID - Caroff2011 ER - TY - JOUR AU - D'Abreu, A. AU - Akbar, U. AU - Friedman, J. H. PY - 2018 DA - 2018// TI - Tardive dyskinesia: epidemiology JO - J Neurol Sci VL - 389 UR - https://doi.org/10.1016/j.jns.2018.02.007 DO - 10.1016/j.jns.2018.02.007 ID - D'Abreu2018 ER - TY - JOUR AU - Martino, D. AU - Morgante, F. PY - 2017 DA - 2017// TI - Movement disorders and chronic psychosis JO - Neurol Clin Pract VL - 7 UR - https://doi.org/10.1212/CPJ.0000000000000344 DO - 10.1212/CPJ.0000000000000344 ID - Martino2017 ER - TY - JOUR AU - Caroff, S. N. AU - Ungvari, G. S. AU - Cunningham Owens, D. G. PY - 2018 DA - 2018// TI - Historical perspectives on tardive dyskinesia JO - J Neurol Sci VL - 389 UR - https://doi.org/10.1016/j.jns.2018.02.015 DO - 10.1016/j.jns.2018.02.015 ID - Caroff2018 ER - TY - STD TI - Teva Pharmaceutical Industries Ltd. Teva Announces FDA approval of AUSTEDO® (deutetrabenazine) tablets for the treatment of tardive dyskinesia in adults. 2017. http://www.tevapharm.com/news/teva_announces_fda_approval_of_austedo_deutetrabenazine_tablets_for_the_treatment_of_tardive_dyskinesia_in_adults_08_17.aspx. Accessed 31 Jan 2019. UR - http://www.tevapharm.com/news/teva_announces_fda_approval_of_austedo_deutetrabenazine_tablets_for_the_treatment_of_tardive_dyskinesia_in_adults_08_17.aspx ID - ref22 ER - TY - JOUR AU - Touma, K. T. B. AU - Scarff, J. R. PY - 2018 DA - 2018// TI - Valbenazine and deutetrabenazine for tardive dyskinesia JO - Innov Clin Neurosci VL - 15 ID - Touma2018 ER - TY - JOUR AU - Woods, S. W. PY - 2003 DA - 2003// TI - Chlorpromazine equivalent doses for the newer atypical antipsychotics JO - J Clin Psychiatry VL - 64 UR - https://doi.org/10.4088/JCP.v64n0607 DO - 10.4088/JCP.v64n0607 ID - Woods2003 ER - TY - JOUR AU - Atkins, M. AU - Burgess, A. AU - Bottomley, C. AU - Riccio, M. PY - 1997 DA - 1997// TI - Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications JO - Psychiatr Bull VL - 21 UR - https://doi.org/10.1192/pb.21.4.224 DO - 10.1192/pb.21.4.224 ID - Atkins1997 ER - TY - JOUR AU - Leucht, S. AU - Samara, M. AU - Heres, S. AU - Patel, M. X. AU - Woods, S. W. AU - Davis, J. M. PY - 2014 DA - 2014// TI - Dose equivalents for second-generation antipsychotics: the minimum effective dose method JO - Schizophr Bull VL - 40 UR - https://doi.org/10.1093/schbul/sbu001 DO - 10.1093/schbul/sbu001 ID - Leucht2014 ER - TY - JOUR AU - Charlson, M. E. AU - Pompei, P. AU - Ales, K. L. AU - CR, M. K. PY - 1987 DA - 1987// TI - A new method of classifying prognostic comorbidity in longitudinal studies: development and validation JO - J Chronic Dis VL - 40 UR - https://doi.org/10.1016/0021-9681(87)90171-8 DO - 10.1016/0021-9681(87)90171-8 ID - Charlson1987 ER - TY - STD TI - de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 2003;56 3:221–229. ID - ref28 ER - TY - JOUR AU - Yassa, R. AU - Jeste, D. V. PY - 1992 DA - 1992// TI - Gender differences in tardive dyskinesia: a critical review of the literature JO - Schizophr Bull VL - 18 UR - https://doi.org/10.1093/schbul/18.4.701 DO - 10.1093/schbul/18.4.701 ID - Yassa1992 ER - TY - JOUR AU - Miller, D. D. AU - Caroff, S. N. AU - Davis, S. M. AU - Rosenheck, R. A. AU - McEvoy, J. P. AU - Saltz, B. L. PY - 2008 DA - 2008// TI - Extrapyramidal side-effects of antipsychotics in a randomised trial JO - Br J Psychiatry VL - 193 UR - https://doi.org/10.1192/bjp.bp.108.050088 DO - 10.1192/bjp.bp.108.050088 ID - Miller2008 ER - TY - JOUR AU - Peluso, M. J. AU - Lewis, S. W. AU - Barnes, T. R. AU - Jones, P. B. PY - 2012 DA - 2012// TI - Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs JO - Br J Psychiatry VL - 200 UR - https://doi.org/10.1192/bjp.bp.111.101485. DO - 10.1192/bjp.bp.111.101485. ID - Peluso2012 ER - TY - JOUR AU - Woods, S. W. AU - Morgenstern, H. AU - Saksa, J. R. AU - Walsh, B. C. AU - Sullivan, M. C. AU - Money, R. PY - 2010 DA - 2010// TI - Incidence of tardive dyskinesia with atypical and conventional antipsychotic medications: prospective cohort study JO - J Clin Psychiatry VL - 71 UR - https://doi.org/10.4088/JCP.07m03890yel DO - 10.4088/JCP.07m03890yel ID - Woods2010 ER - TY - JOUR AU - Zutshi, D. AU - Cloud, L. J. AU - Factor, S. A. PY - 2014 DA - 2014// TI - Tardive syndromes are rarely reversible after discontinuing dopamine receptor blocking agents: experience from a university-based movement disorder clinic JO - Tremor Other Hyperkinet Mov (N Y) VL - 4 UR - https://doi.org/10.7916/D8MS3R8C DO - 10.7916/D8MS3R8C ID - Zutshi2014 ER - TY - JOUR AU - Cortese, L. AU - Jog, M. AU - McAuley, T. J. AU - Kotteda, V. AU - Costa, G. PY - 2004 DA - 2004// TI - Assessing and monitoring antipsychotic-induced movement disorders in hospitalized patients: a cautionary study JO - Can J Psychiatr VL - 49 UR - https://doi.org/10.1177/070674370404900105 DO - 10.1177/070674370404900105 ID - Cortese2004 ER -